CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to pr...
Enregistré dans:
Auteurs principaux: | Jun Zhang, Xilin He, Yajie Wan, Honghong Zhang, Tao Tang, Meng Zhang, Shiyi Yu, Weiyong Zhao, Liming Chen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012) -
Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
par: Shanshan Zhang, et autres
Publié: (2021) -
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
par: David MARKS, et autres
Publié: (2021) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013) -
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)